SteriMax Inc. Email Format
Pharmaceutical ManufacturingOntario, Canada51-200 Employees
SteriMax Inc. is a privately held, wholly owned Canadian pharmaceutical manufacturer based in Oakville, Ontario. The company develops, manufactures, and distributes injectable medications intended for hospital and retail pharmacy use. It operates in the Canadian pharmaceutical manufacturing sector, providing treatments that support clinical care across the healthcare system. A recent development is the January 2020 launch of Arsenic Trioxide for Injection. In 2018, the company added several injectable therapies, including Mycophenolate Mofetil for Injection USP 500 mg, Ethacrynate Sodium for injection, and Bupivacaine Hydrochloride for injection, illustrating a focus on hospital-focused formulations.